ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

IMAX Soars to Highest Grossing Chinese New Year Ever with $53 Million

IMAX Box Office in China’s Peak Moviegoing Period up +57% over Previous Best; Animated Blockbuster “Ne Zha 2” Leads the Way with $36 Million and Counting

IMAX Corporation (NYSE: IMAX) shattered its box office record for Chinese New Year, delivering $53 million during the 7-day holiday period concluded February 4. The busiest window annually for moviegoing in China, the 2025 Chinese New Year holiday saw IMAX exceed its previous record of $34 million set in 2023 by a whopping +57%. IMAX also delivered its highest attendance ever for the Chinese New Year, with 5.5 million admissions nationwide.

While the holiday has concluded, IMAX’s record-breaking slate of Chinese New Year films will continue to play throughout the IMAX China network for another month. IMAX delivered its highest market share of the holiday – 4.3% on only 1% of screens – and $7.2 million on the final day of the period, demonstrating the continued strength of the slate.

“Chinese New Year unleashed one of the most impressive surges in moviegoing we’ve seen in recent years, anywhere in the world — leaving a slew of broken IMAX records in its wake,” said Rich Gelfond, CEO of IMAX. “This is a shot of adrenaline for moviegoing in China that comes at just the right time, with a tentpole heavy slate of local language and Hollywood films ahead for 2025.”

Enlight’s “Ne Zha 2” — the highly anticipated sequel to the 2019 smash hit — led the way with $36 million. The film scored the biggest opening weekend in IMAX history for an animated film with $22 million and is already the fourth highest grossing IMAX local language release of all time. “Ne Zha 2” took just seven days to top its predecessor “Ne Zha”, which earned $35 million in China over its two-month IMAX run.

Alibaba’s fantasy “Creation of the Gods II: Demon Force” delivered $7.6 million and Bona’s naval drama “Operation Hadal” added another $2.7 million in IMAX. Both films featured IMAX-exclusive expanded aspect ratio. China Film Group’s martial arts actioner “Legend of the Condor Heroes: The Gallants” scored $3.7 million while Maoyan’s “Detective Chinatown 1900” contributed an additional $2.7 million in IMAX.

"The message from audiences is clear: IMAX is their first choice," said Daniel Manwaring, CEO of IMAX China. "Riding on a stronger-than-ever audience preference, IMAX has transformed moviegoing into a cultural phenomenon and a social talking point. We deeply value their brand loyalty and are confident that we can carry this momentum throughout what is poised to be one of the strongest years for Chinese local language films."

With the 2025 Chinese New Year slate, IMAX continues to expand its strategy of bringing local language films to audiences around the world. “Creation of The Gods II: Demon Force” and “Detective Chinatown 1900” were also released in select IMAX locations across 11 countries worldwide, bringing in more than $1.2 million outside of China. “Ne Zha 2" will be shown exclusively in IMAX locations in Australia and New Zealand beginning February 6th.

The Chinese New Year slate will continue to play in China for the next month, alongside Disney’s “Captain America: Brave New World” and the re-release of the classic romance “In the Mood for Love".

About IMAX China

IMAX China is a subsidiary of IMAX Corporation and was incorporated as a limited liability company under the laws of Cayman Islands. IMAX China was established by IMAX Corporation specifically to oversee the expansion of IMAX's business throughout Greater China. Shares of IMAX China trade on the Hong Kong Stock Exchange under the stock code “1970.”

About IMAX Corporation

IMAX, an innovator in entertainment technology, combines proprietary software, architecture, and equipment to create experiences that take you beyond the edge of your seat to a world you've never imagined. Top filmmakers and studios are utilizing IMAX systems to connect with audiences in extraordinary ways, making IMAX's network among the most important and successful theatrical distribution platforms for major event films around the globe.

IMAX is headquartered in New York, Toronto, and Los Angeles, with additional offices in London, Dublin, Tokyo, and Shanghai. As of September 30, 2024, there were 1,788 IMAX systems (1,714 commercial multiplexes, 12 commercial destinations, 62 institutional) operating in 89 countries and territories. Shares of IMAX China Holding, Inc., a subsidiary of IMAX Corporation, trade on the Hong Kong Stock Exchange under the stock code “1970”.

IMAX®, IMAX® 3D, Experience It In IMAX®, The IMAX Experience®, DMR®, Filmed For IMAX®, IMAX LIVE™, and IMAX Enhanced® are trademarks and trade names of IMAX Corporation or its subsidiaries that are registered or otherwise protected under laws of various jurisdictions. For more information, visit www.imax.com. You may also connect with IMAX on Instagram (www.instagram.com/imax), Facebook (www.facebook.com/imax), LinkedIn (www.linkedin.com/company/imax), X (www.twitter.com/imax), and YouTube (www.youtube.com/imaxmovies).

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.22
+21.36 (9.58%)
AAPL  270.37
-1.03 (-0.38%)
AMD  256.12
+1.28 (0.50%)
BAC  53.45
+0.42 (0.79%)
GOOG  281.82
-0.08 (-0.03%)
META  648.35
-18.12 (-2.72%)
MSFT  517.81
-7.95 (-1.51%)
NVDA  202.49
-0.40 (-0.20%)
ORCL  262.61
+5.72 (2.23%)
TSLA  456.56
+16.46 (3.74%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.